Online training on skin cancer diagnosis in rheumatologists: Results from a nationwide randomized web-based survey

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Viguier, Manuelle ^a,b   Rist, Stéphanie ^c   Aubin, François ^d   Leccia, Marie Thérèse ^e   Richard, Marie Aleth ^f   Esposito Farèse, Marina ^a,g,h   Gaudin, Philippe ⁱ   Pham, Thao ^j   Richette, Pascal ^a   Wendling, Daniel ^d   Sibilia, Jean ^k   Tubach, Florence ^a,g,h   Amoura, Zahir ^l   Benveniste, Olivier ^l   Boyer, Olivier ^l   Durez, Patrick ^l   Fautrel, Bruno ^l   Guerne, Pierre André ^l   Hachulla, Eric ^l   Jullien, Denis ^l   Mouthon, Luc ^l   Puechal, Xavier ^l   Sellam, Jérémie ^l   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^d UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h INSERM   (France)

ⁱ Hopital Sud CHU de Grenoble   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^k UNIVERSITÉ DE STRASBOURG   (France)

^l Université Paris Diderot Hôpital Lariboisière Service de Rhumatologie ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ACCESS TO INFORMATION; ADULT; ARTICLE; BASAL CELL CARCINOMA; BIOLOGICAL THERAPY; CANCER RISK; COMEDO; CONTROLLED STUDY; DERMATOFIBROMA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; EPIDERMOID CYST; FEMALE; FRENCHMAN; HUMAN; HUMAN EXPERIMENT; INTERNET; KNOWLEDGE BASE; LIKERT SCALE; MALE; MEDICAL EDUCATION; MEDICAL PHOTOGRAPHY; MULTIPLE CHOICE TEST; NORMAL HUMAN; ONLINE SYSTEM; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRECANCER; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK ASSESSMENT; SELF ESTEEM; SKIN CANCER; SKIN DEFECT; SKIN EXAMINATION; SKIN LYMPHOMA; SKIN PROTECTION; SKIN TUMOR; SMOKING CESSATION; SQUAMOUS CELL CARCINOMA; VERRUCA PLANTARIS; MIDDLE AGED; PHYSICIAN; QUESTIONNAIRE; SKIN NEOPLASMS;

ADULT; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; PHYSICIANS; RHEUMATOLOGY; SKIN NEOPLASMS; SURVEYS AND QUESTIONNAIRES;

EID: 84930639831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127564     Document Type: Article

References (12)

1. Mercer L, Green AC, Galloway JB, Davies R, Lunt M, Dixon WG, et al. The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2012; 71: 869-874. doi: 10.1136/annrheumdis-2011-200622 PMID: 22241900
2. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis. 2005; 64: 1421-1426. PMID: 15829572
3. Mellemkjaer L, Linet MS, Gridley G, Frisch M, Møller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996; 32A: 1753-1757. PMID: 8983286
4. Mariette X, Matucci-Cerinic M, Pavelka K, Taylor P, van Vollenhoven R, Heatley R, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis. 2011; 70: 1895-1904. doi: 10.1136/ard.2010.149419 PMID: 21885875
5. Mariette X, Vaughan Reynolds A, Emery P. Updated meta-analysis of non melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors. Ann Rheum Dis. 2012; 71: e2. doi: 10.1136/annrheumdis-2012-202478 PMID: 23014259
6. Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 2007; 56: 2886-2895. PMID: 17729297
7. Askling J, Fahrbach K, Nordstrom B, Ross S, Schmid CH, Symmons D. Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials with adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf. 2011; 20: 119-130. doi: 10.1002/pds.2046 PMID: 21254282
8. Askling J on behalf of the ARTIS Study Group. Anti-TNF therapy and risk of skin cancer, data from the Swedish ARTIS Registry 1998-2006. Ann Rheum Dis. 2009; 68 Suppl 3: 423.
9. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014; 73: 62-68. doi: 10.1136/annrheumdis-2013-204223 PMID: 24095940
10. Pham T, Bachelez H, Berthelot JM, Blacher J, Bouhnik Y, Claudepierre P, et al. TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine 2011; 78 Suppl 1: 15-185. doi: 10.1016/S1297-319X (11)70001-X PMID: 21703545
11. Grange F, Woronoff AS, Bera R, Colomb M, Lavole B, Fournier E, et al. Efficacy of a general practitioner training campaign for early detection of melanoma in France. Br J Dermatol. 2014; 170: 123-129. doi: 10.1111/bjd.12585 PMID: 23937244
12. Geller AC, Swetter SM, Oliveria S, Dusza S, Halpern AC. Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol. 2011; 65 Suppl 1: 587-594.